Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer von Nagore, G., Moreno-Olmedo, E., Suárez-Gironzini, V., Aakki, L., LI, Ramos-Garcia, Gómez, E., Garcia, A., Beltran, L., Gomez-Iturriaga, A.

Volltext

Reirradiation (RRT) tolerance in head and neck carcinoma (CCC) von Peinado Serrano, J, Suarez Gironzini, V, Pachón, J, Ruiz Ruiz, Y, Ortiz Gordillo, M

Volltext

Bilateral abdominal neuroblastoma patient in 18 months: Treatment planning von Campos Triviño, B, Suarez Gironzini, V, Peinado Serrano, J, Cabrera Roldan, P

Volltext

PO-1369 HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer von Moreno Olmedo, E., Nagore, G., Suárez Gironzini, V., Minguez, C., Gómez, E., Garcia, A., Ciapa, V., Marrone, I., López, E.

Volltext

PP-0159 HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer von Moreno Olmedo, E., Nagore, G., Suárez-Gironzini, V., Minguez, C., Gómez, E., Garcia, A., Ciapa, V., Marrone, I., López, E.

Volltext

Best oral presentation: Prevention of mucositis in head and neck cancer (HNC) with glutamine von Ibáñez, J. Pachón, Ángel, B. Quintana, Gironzini, V. Suárez

Volltext